Effects of cytokine deficiency on chemokine expression in CNS of mice with EAE

被引:45
作者
Matejuk, A
Dwyer, J
Ito, A
Bruender, Z
Vandenbark, AA
Offner, H
机构
[1] Vet Affairs Med Ctr, R&D 31, Portland, OR 97201 USA
[2] Oregon Hlth & Sci Univ, Dept Neurol, Portland, OR 97201 USA
[3] Polish Acad Sci, L Hirszfeld Inst Immunol & Expt Therapy, Wroclaw, Poland
[4] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97201 USA
关键词
rodent; EAE/MS; chemokines; cytokines; transgenic/knockout;
D O I
10.1002/jnr.10156
中图分类号
Q189 [神经科学];
学科分类号
071006 [神经生物学];
摘要
Although both cytokines and chemokines have been implicated in the pathogenesis of clinical and histological EAE, their interactions in vivo have not yet been clearly established. To address this issue, we evaluated expression of chemokines and receptors in the CNS of wildtype control and cytokine deficient mice at the peak of EAE induced with MOG-35-55 peptide in CFA. Our results demonstrate that: 1) expression of most chemokines/receptors was drastically inhibited in TNF-alpha deficient mice, and was reflective of delayed onset and reduced severity of EAE; 2) distinct patterns of chemokine expression occurred in various other cytokine knockout mice that did not significantly affect expression of clinical EAE; 3) there was a strong association between expression of MIP-lalpha, MIP-2 and MCP-1 in CNS and overall severity of EAE in wild-type and cytokine knockout mice; and 4) among CNS infiltrating cells at the peak of EAE, macrophages and CD8+ T cells were the primary cellular source of most of the chemokines. Of note, we present evidence that TNF-alpha may be involved in regulating RANTES and MIP-1alpha, and that IL-4 may be involved in regulating MCP-1. Our results not only identify the cellular source of chemokines in CNS, but also implicate MIP-1alpha, MIP-2, and MCP-1 in controlling CNS inflammation and severity of EAE. (C) 2002 Wiley-Liss, Inc.
引用
收藏
页码:680 / 688
页数:9
相关论文
共 55 条
[1]
CONTROL OF ESTABLISHED EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS BY INHIBITION OF TUMOR-NECROSIS-FACTOR (TNF) ACTIVITY WITHIN THE CENTRAL-NERVOUS-SYSTEM USING MONOCLONAL-ANTIBODIES AND TNF RECEPTOR IMMUNOGLOBULIN FUSION PROTEINS [J].
BAKER, D ;
BUTLER, D ;
SCALLON, BJ ;
ONEILL, JK ;
TURK, JL ;
FELDMANN, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (09) :2040-2048
[2]
CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[3]
Bettelli E, 1998, J IMMUNOL, V161, P3299
[4]
Bitsch A, 2000, GLIA, V29, P366, DOI 10.1002/(SICI)1098-1136(20000215)29:4<366::AID-GLIA7>3.0.CO
[5]
2-Y
[6]
Failure to suppress the expansion of the activated CD4 T cell population in interferon γ-deficient mice leads to exacerbation of experimental autoimmune encephalomyelitis [J].
Chu, CQ ;
Wittmer, S ;
Dalton, DK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (01) :123-128
[7]
Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis [J].
Cua, DJ ;
Groux, H ;
Hinton, DR ;
Stohlman, SA ;
Coffman, RL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (06) :1005-1010
[8]
Eugster HP, 1999, EUR J IMMUNOL, V29, P626, DOI 10.1002/(SICI)1521-4141(199902)29:02<626::AID-IMMU626>3.0.CO
[9]
2-A
[10]
Falcone M, 1998, J IMMUNOL, V160, P4822